 <h1>Metoprolol Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of metoprolol include:</b> cardiac failure, bradycardia, and hypotension.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to metoprolol: oral capsule extended release, oral powder for solution, oral tablet, oral tablet extended release</i></p><p>Other dosage forms:</p><ul><li>intravenous solution</li></ul><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet, Extended Release)</p><p>Exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred after abrupt cessation of therapy with certain beta-blocking agents. When discontinuing chronic therapy, gradually reduce the dose over a period of 1 to 2 weeks and monitor the patient carefully. If angina markedly worsens or acute coronary insufficiency develops, reinstate administration promptly, at least temporarily, and take other measures appropriate for the management of unstable angina. Warn patients not to interrupt or discontinue therapy without physician advice.</p><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred. The dosage should be gradually reduced over a period of 1 to 2 weeks and the patient should be carefully monitored when discontinuing chronic therapy. If angina markedly worsens or acute coronary insufficiency develops, metoprolol tartrate administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken. Patients should be warned against interruption or discontinuation of therapy without the physician's advice. Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue metoprolol tartrate therapy abruptly even in patients treated only for hypertension.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, metoprolol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking metoprolol:</p><p>
<i>More common</i>
</p><ul>
<li>Blurred vision</li>
<li>chest pain or discomfort</li>
<li>confusion</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>slow or irregular heartbeat</li>
<li>sweating</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>cough</li>
<li>decreased urine output</li>
<li>difficult or labored breathing</li>
<li>difficulty with speaking</li>
<li>dilated neck veins</li>
<li>disturbed color perception</li>
<li>double vision</li>
<li>extreme tiredness or weakness</li>
<li>fast, pounding, or racing heartbeat or pulse</li>
<li>halos around lights</li>
<li>headache</li>
<li>inability to move the arms, legs, or facial muscles</li>
<li>inability to speak</li>
<li>irregular breathing</li>
<li>loss of vision</li>
<li>night blindness</li>
<li>noisy breathing</li>
<li>overbright appearance of lights</li>
<li>pain, tension, and weakness upon walking that subsides during periods of rest</li>
<li>paleness or cold feeling in the fingertips and toes</li>
<li>rapid weight gain</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>short-term memory loss</li>
<li>slow speech</li>
<li>swelling of the face, fingers, feet, or lower legs</li>
<li>tightness in the chest</li>
<li>tingling of the hands or feet</li>
<li>tingling or pain in the fingers or toes when exposed to cold temperatures</li>
<li>troubled breathing</li>
<li>tunnel vision</li>
<li>unusual weight gain or loss</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Bluish color of the skin of the fingers or toes</li>
<li>chills</li>
<li>clay-colored stools</li>
<li>continuing loss of appetite</li>
<li>continuing or severe abdominal or stomach pain</li>
<li>continuing or severe nausea and vomiting</li>
<li>dark urine</li>
<li>difficulty with moving</li>
<li>fever</li>
<li>general tiredness and weakness</li>
<li>hoarseness</li>
<li>increased frequency of urination</li>
<li>itching skin</li>
<li>light-colored stools</li>
<li>lower back or side pain</li>
<li>muscle pain or stiffness</li>
<li>numbness of the fingers or toes</li>
<li>pain, swelling, or redness in the joints</li>
<li>rash</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>unpleasant breath odor</li>
<li>unusual bleeding or bruising</li>
<li>upper right abdominal or stomach pain</li>
<li>vomiting of blood</li>
<li>weakness</li>
<li>yellow eyes and skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bleeding gums</li>
<li>blood in the urine or stools</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>cool, sweaty skin</li>
<li>pinpoint red spots on the skin</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking metoprolol:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Bluish color of the fingernails, lips, skin, palms, or nail beds</li>
<li>change in consciousness</li>
<li>loss of consciousness</li>
<li>no blood pressure or pulse</li>
<li>stopping of the heart</li>
<li>very drowsy or sleepy</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of metoprolol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Belching</li>
<li>bloated feeling</li>
<li>decreased interest in sexual intercourse</li>
<li>difficulty having a bowel movement</li>
<li>discouragement</li>
<li>dry mouth</li>
<li>excess air or gas in stomach or bowels</li>
<li>feeling of constant movement of self or surroundings</li>
<li>feeling of fullness</li>
<li>feeling of indigestion</li>
<li>feeling sad or empty</li>
<li>inability to have or keep an erection</li>
<li>irritability</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>loss of interest or pleasure</li>
<li>nightmares</li>
<li>pain in the chest below the breastbone</li>
<li>passing gas</li>
<li>redness or other discoloration of the skin</li>
<li>runny nose</li>
<li>sensation of spinning</li>
<li>sneezing</li>
<li>stuffy nose</li>
<li>tiredness</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Bone pain</li>
<li>continuing ringing or buzzing or other unexplained noise in the ears</li>
<li>dry eyes</li>
<li>hair loss or thinning of the hair</li>
<li>hearing loss</li>
<li>increased sensitivity of the skin to sunlight</li>
<li>pain in the penis on erection</li>
<li>severe sunburn</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Change in taste or bad, unusual, or unpleasant (after) taste</li>
<li>fear or nervousness</li>
<li>hives or welts</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to metoprolol: compounding powder, injectable solution, oral capsule extended release, oral solution, oral tablet, oral tablet extended release</i></p><h3>General</h3><p>The most common adverse reactions were tiredness, dizziness, depression, shortness of breath, bradycardia, hypotension, diarrhea, pruritus, and rash.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Heart failure (up to 27.5%), hypotension (systolic blood pressure less than 90 mmHg) (up to 27.4%), bradycardia (heart rate less than 40 beats per minute) (up to 15.9%),</p>
<p><b>Common</b> (1% to 10%): Cold extremities, arterial insufficiency, palpitation, first degree heart block (P-R interval 0.26 seconds or greater), second or third degree heart block, postural disorders</p>
<p><b>Uncommon</b> (0.1% to 1%): Cardiogenic shock in patients with acute myocardial infarction</p>
<p><b>Rare</b> (0.01% to 0.1%): Disturbances of cardiac conduction, cardiac arrhythmia</p>
<p><b>Very rare</b> (less than 0.01%): Intermittent claudication increased</p>
<p><b>Frequency not reported</b>: Claudication<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, nausea, dry mouth, gastric pain, constipation, flatulence, heartburn, abdominal pain, vomiting</p>
<p><b>Frequency not reported</b>: Retroperitoneal fibrosis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Tiredness, peripheral edema, accident and/or injury, death, fatigue</p>
<p><b>Uncommon</b> (0.1% to 1%): Edema, precordial pain</p>
<p><b>Frequency not reported</b>: Lactic dehydrogenase elevated</p>
<p><b>Postmarketing reports</b>: Chest pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, vertigo, stroke, headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Paresthesia, somnolence, impaired concentration</p>
<p><b>Rare</b> (0.01% to 0.1%): Alertness decreased</p>
<p><b>Very rare</b> (less than 0.01%): Amnesia/memory impairment, tinnitus, taste disturbance</p>
<p><b>Frequency not reported</b>: Short-term memory loss</p>
<p><b>Postmarketing reports</b>: Syncope<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Shortness of breath, wheezing, dyspnea</p>
<p><b>Rare</b> (less than 0.1%): Rhinitis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Sweating increased</p>
<p><b>Rare</b> (0.01% to 0.1%): Loss of hair</p>
<p><b>Very rare</b> (less than 0.01%): Photosensitivity reactions, psoriasis aggravated, gangrene in patients with preexisting severe peripheral circulatory disorders, hyperhidrosis, alopecia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression</p>
<p><b>Uncommon</b> (0.1% to 1%): Insomnia, nightmare</p>
<p><b>Rare</b> (0.01% to 0.1%): Nervousness, anxiety</p>
<p><b>Very rare</b> (less than 0.01%): Confusion, hallucination, personality disorder, disturbances of libido</p>
<p><b>Frequency not reported</b>: Sleep disturbance<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Muscle cramps</p>
<p><b>Very rare</b> (less than 0.01%): Arthralgia, arthritis</p>
<p><b>Frequency not reported</b>: Musculoskeletal pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Weight gain</p>
<p><b>Frequency not reported</b>: Unstable diabetes</p>
<p><b>Postmarketing reports</b>: Blood triglycerides increased, high density lipoprotein (HDL) decreased<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Visual disturbance, dry and/or irritated eyes, conjunctivitis</p>
<p><b>Frequency not reported</b>: Blurred vision<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (0.01% to 0.1%): Liver function test abnormalities</p>
<p><b>Very rare</b> (less than 0.01%): Hepatitis</p>
<p><b>Frequency not reported</b>: Transaminase elevated, alkaline phosphatase elevated</p>
<p><b>Postmarketing reports</b>: Jaundice, non-specific hepatic dysfunction<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (0.01% to 0.1%): Impotence/sexual dysfunction</p>
<p><b>Very rare</b> (less than 0.01%): Peyronie's disease<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Rare</b> (less than 0.1%): Positive antinuclear antibodies<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very rare</b> (less than 0.01%): Thrombocytopenia</p>
<p><b>Frequency not reported</b>: Agranulocytosis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Lopressor (metoprolol)." Novartis Pharmaceuticals, East Hanover, NJ. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Metoprolol Tartrate vs Succinate - What's the difference between them?</li>
<li>What is Prolomet XL 50? What is the mechanism of action and what are this medicine side effects?</li>
<li>How is atenolol superior to metoprolol?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about metoprolol</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>En Español</li>
<li>478 Reviews</li>
<li>Drug class: cardioselective beta blockers</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Metoprolol &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Metoprolol Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Toprol-XL, Lopressor</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +7 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Atrial Fibrillation</li>
<li>Angina</li>
<li>Angina Pectoris Prophylaxis</li>
<li>Aortic Aneurysm</li>
<li data-more-config-id="list-data-resources-conditions">... +10 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to metoprolol: compounding powder, injectable solution, oral capsule extended release, oral solution, oral tablet, oral tablet extended release</i></p><h3>General</h3><p>The most common adverse reactions were tiredness, dizziness, depression, shortness of breath, bradycardia, hypotension, diarrhea, pruritus, and rash.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Heart failure (up to 27.5%), hypotension (systolic blood pressure less than 90 mmHg) (up to 27.4%), bradycardia (heart rate less than 40 beats per minute) (up to 15.9%),</p><p><b>Common</b> (1% to 10%): Cold extremities, arterial insufficiency, palpitation, first degree heart block (P-R interval 0.26 seconds or greater), second or third degree heart block, postural disorders</p><p><b>Uncommon</b> (0.1% to 1%): Cardiogenic shock in patients with acute myocardial infarction</p><p><b>Rare</b> (0.01% to 0.1%): Disturbances of cardiac conduction, cardiac arrhythmia</p><p><b>Very rare</b> (less than 0.01%): Intermittent claudication increased</p><p><b>Frequency not reported</b>: Claudication<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, nausea, dry mouth, gastric pain, constipation, flatulence, heartburn, abdominal pain, vomiting</p><p><b>Frequency not reported</b>: Retroperitoneal fibrosis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Tiredness, peripheral edema, accident and/or injury, death, fatigue</p><p><b>Uncommon</b> (0.1% to 1%): Edema, precordial pain</p><p><b>Frequency not reported</b>: Lactic dehydrogenase elevated</p><p><b>Postmarketing reports</b>: Chest pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, vertigo, stroke, headache</p><p><b>Uncommon</b> (0.1% to 1%): Paresthesia, somnolence, impaired concentration</p><p><b>Rare</b> (0.01% to 0.1%): Alertness decreased</p><p><b>Very rare</b> (less than 0.01%): Amnesia/memory impairment, tinnitus, taste disturbance</p><p><b>Frequency not reported</b>: Short-term memory loss</p><p><b>Postmarketing reports</b>: Syncope<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Shortness of breath, wheezing, dyspnea</p><p><b>Rare</b> (less than 0.1%): Rhinitis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash</p><p><b>Uncommon</b> (0.1% to 1%): Sweating increased</p><p><b>Rare</b> (0.01% to 0.1%): Loss of hair</p><p><b>Very rare</b> (less than 0.01%): Photosensitivity reactions, psoriasis aggravated, gangrene in patients with preexisting severe peripheral circulatory disorders, hyperhidrosis, alopecia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression</p><p><b>Uncommon</b> (0.1% to 1%): Insomnia, nightmare</p><p><b>Rare</b> (0.01% to 0.1%): Nervousness, anxiety</p><p><b>Very rare</b> (less than 0.01%): Confusion, hallucination, personality disorder, disturbances of libido</p><p><b>Frequency not reported</b>: Sleep disturbance<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Muscle cramps</p><p><b>Very rare</b> (less than 0.01%): Arthralgia, arthritis</p><p><b>Frequency not reported</b>: Musculoskeletal pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Weight gain</p><p><b>Frequency not reported</b>: Unstable diabetes</p><p><b>Postmarketing reports</b>: Blood triglycerides increased, high density lipoprotein (HDL) decreased<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Visual disturbance, dry and/or irritated eyes, conjunctivitis</p><p><b>Frequency not reported</b>: Blurred vision<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (0.01% to 0.1%): Liver function test abnormalities</p><p><b>Very rare</b> (less than 0.01%): Hepatitis</p><p><b>Frequency not reported</b>: Transaminase elevated, alkaline phosphatase elevated</p><p><b>Postmarketing reports</b>: Jaundice, non-specific hepatic dysfunction<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (0.01% to 0.1%): Impotence/sexual dysfunction</p><p><b>Very rare</b> (less than 0.01%): Peyronie's disease<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Rare</b> (less than 0.1%): Positive antinuclear antibodies<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very rare</b> (less than 0.01%): Thrombocytopenia</p><p><b>Frequency not reported</b>: Agranulocytosis<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Lopressor (metoprolol)." Novartis Pharmaceuticals, East Hanover, NJ. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Metoprolol Tartrate vs Succinate - What's the difference between them?</li>
<li>What is Prolomet XL 50? What is the mechanism of action and what are this medicine side effects?</li>
<li>How is atenolol superior to metoprolol?</li>
</ul><h2>More about metoprolol</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>En Español</li>
<li>478 Reviews</li>
<li>Drug class: cardioselective beta blockers</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Metoprolol &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Metoprolol Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +7 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Atrial Fibrillation</li>
<li>Angina</li>
<li>Angina Pectoris Prophylaxis</li>
<li>Aortic Aneurysm</li>
<li data-more-config-id="list-data-resources-conditions">... +10 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>